therapeutics

January 4, 2018January 4, 2018

GSK Researchers Identify Potential Target for Therapeutics to Promote MS Remyelination

News

Researchers at GlaxoSmithKline (GSK) have identified the histamine receptor 3 (H3R) as a potential new therapeutic target for promoting remyelination in patients with multiple sclerosis (MS). Their study ... Read more

December 19, 2017December 19, 2017

Additional Diseases Increase Risk of MS Relapses, Canadian Study Shows

News

Multiple sclerosis patients with additional diseases, high cholesterol levels or a history of migraine headaches are more likely to experience relapses than other patients, a Canadian ... Read more

December 16, 2015December 16, 2015

MS May Be Triggered by the Death of Brain Cells

News

Researchers are proposing for a first time that multiple sclerosis (MS) is triggered by the death of a specific cell population within the central nervous system called oligodendrocytes. ... Read more

Pin It on Pinterest